Latest Posts

30

May 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...
Read More

22

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
Try Ontosight® For Free

OUR PIPELINE

With our partners in Biotech and Pharma we have built a track record of 32+ successful drug discovery and development partnerships at multiple stages of maturity, clinical development and market readiness. Together with our partners we drive therapeutics programs through all relevant inflection points independent of disease  area and therapeutic modality.
Therapeutic Area Indication Target Stage Partner
Oncology Solid tumors AKAP-4 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Verik bio
Oncology Pancreatic cancer PI3K Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Oncology Multiple oncology indications MetAP2 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Multiple oncology indications OX40 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Pancreatic cancer Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Oncology and Inflammatory diseases Confidential PIM family Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Inflection Biosciences
Immunology Multiple immunology indications IL-17 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Neurodegenerative diseases Alzhiemers disease Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio alpha
Mental health disorders Depression Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Anxiety Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Sleep disorder Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders ADHD Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Opoid abuse Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Schizophrenia Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Sensori-neural diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Metabolic diseases T1D and co-morbidities Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Cardiology Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Dermatology + others Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Dermatology Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Dermatology Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Infectious diseases Antimicrobial resistance Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio beta
Infectious diseases Covid-19 3CLPro Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Pain related indications Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
ICU treatment Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Rare diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Rare diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Multiple TAs Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Oncology Solid tumors AKAP-4 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Verik bio
Oncology Pancreatic cancer PI3K Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Oncology Multiple oncology indications MetAP2 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Multiple oncology indications OX40 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Pancreatic cancer Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Oncology and Inflammatory diseases Confidential PIM family Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Inflection Biosciences
Therapeutic Area Indication Target Stage Partner
Immunology Multiple immunology indications IL-17 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Therapeutic Area Indication Target Stage Partner
Neurodegenerative diseases Alzhiemers disease Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio alpha
Mental health disorders Depression Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Anxiety Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Sleep disorder Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders ADHD Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Opoid abuse Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Schizophrenia Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Sensori-neural diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Metabolic diseases T1D and co-morbidities Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Cardiology Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Dermatology + others Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Dermatology Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Dermatology Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Therapeutic Area Indication Target Stage Partner
Infectious diseases Antimicrobial resistance Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio beta
Infectious diseases Covid-19 3CLPro Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Pain related indications Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
ICU treatment Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Chain Pharmaceuticals
Therapeutic Area Indication Target Stage Partner
Rare diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Rare diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Multiple TAs Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Oncology Solid tumors AKAP-4 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Verik bio
Oncology Pancreatic cancer PI3K Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Oncology Multiple oncology indications MetAP2 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Multiple oncology indications OX40 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Pancreatic cancer Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Oncology and Inflammatory diseases Confidential PIM family Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Inflection Biosciences
Immunology Multiple immunology indications IL-17 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Neurodegenerative diseases Alzhiemers disease Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio alpha
Mental health disorders Depression Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Anxiety Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Sleep disorder Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders ADHD Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Opoid abuse Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Schizophrenia Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Sensori-neural diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Metabolic diseases T1D and co-morbidities Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Cardiology Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Dermatology + others Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Dermatology Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Dermatology Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Infectious diseases Antimicrobial resistance Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio beta
Infectious diseases Covid-19 3CLPro Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Pain related indications Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
ICU treatment Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Rare diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Rare diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Multiple TAs Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Oncology Solid tumors AKAP-4 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Verik bio
Oncology Pancreatic cancer PI3K Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Oncology Multiple oncology indications MetAP2 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Multiple oncology indications OX40 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Pancreatic cancer Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Oncology and Inflammatory diseases Confidential PIM family Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Inflection Biosciences
Therapeutic Area Indication Target Stage Partner
Immunology Multiple immunology indications IL-17 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Therapeutic Area Indication Target Stage Partner
Neurodegenerative diseases Alzhiemers disease Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio alpha
Mental health disorders Depression Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Anxiety Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Sleep disorder Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders ADHD Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Opoid abuse Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Schizophrenia Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Sensori-neural diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Metabolic diseases T1D and co-morbidities Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Cardiology Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Dermatology + others Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Dermatology Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Dermatology Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Therapeutic Area Indication Target Stage Partner
Infectious diseases Antimicrobial resistance Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio beta
Infectious diseases Covid-19 3CLPro Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Pain related indications Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
ICU treatment Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Therapeutic Area Indication Target Stage Partner
Rare diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Rare diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Multiple TAs Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential